1.
Gerrard G, Payne E, Baker R, Jones D, Potter M, Prentice H, Ethell M, McCullough H, Burgess M, Mehta A, Ganeshaguru K. Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine. Haematologica [Internet]. 2004Jul.1 [cited 2026Nov.8];89(7):782-90. Available from: https://haematologica.org/article/view/3140